The mitoribosome-associated factor Mrx9 acts as a negative regulator of the prohibitin/m-AAA complex
- 1ICB/USP
Abstract
The synthesis of mitochondrial-encoded polypeptides is an essential process, primarily regulated at the posttranscriptional level. In yeast, many regulatory factors have been described as acting in association with the mitoribosome to promote efficient translation; however, the precise mechanisms by which these components function remain largely unknown. Here, we expand on findings concerning a previously studied mitoribosome interactor, Mrx9, which is found in large expressosome-like assemblies of mitoribosome clusters. Mrx9 was initially linked to mitochondrial translation and was suggested to be necessary for splicing of COX1 and COB transcripts. Previous data obtained by others in proximity labelling assays demonstrating that Mrx9 is in close proximity to both the mitoribosome exit tunnel and the prohibitin (PHB) complex. Our current experimental data show that overexpression of Mrx9 impairs the proteolytic functions of Yta10 and Yta12 within the prohibitin complex, leading to splicing defects, accumulation of aberrant polypeptides, and a noticeable impairment in the processing of the essential mitoribosomal protein bL32m. These findings support a regulatory role for Mrx9 in the PHB/m-AAA complex by modulating the activities of both Yta10 and Yta12
Related
- Research progress on the key cuproptosis regulator FDX1 and its relevance to triple-negative breast cancer
- MiR-208b-3p is an upstream regulator of redox-associated cardiomyocyte survival
- The histone methyltransferase complex subunit RBBP5 serves as a central epigenetic regulator of proteostasis dynamics
- Heat-dependent engagement of a buried mitophagy motif in prohibitin 2
- Structural basis for prohibitin-mediated regulation of mitochondrial m-AAA protease
BibTeX
@misc{chagas2026mitoribosomeassociated,
title = {{The mitoribosome-associated factor Mrx9 acts as a negative regulator of the prohibitin/m-AAA complex}},
author = {J. A. Chagas and F. Fontanesi and A. C. Pereira-Antonio and M. H. Barros},
howpublished = {bioRxiv},
year = {2026},
month = jul,
doi = {10.64898/2026.07.28.741247},
url = {https://www.biorxiv.org/content/10.64898/2026.07.28.741247v3},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - The mitoribosome-associated factor Mrx9 acts as a negative regulator of the prohibitin/m-AAA complex
AU - J. A. Chagas
AU - F. Fontanesi
AU - A. C. Pereira-Antonio
AU - M. H. Barros
PY - 2026
DA - 2026/07/28
PB - bioRxiv
DO - 10.64898/2026.07.28.741247
UR - https://www.biorxiv.org/content/10.64898/2026.07.28.741247v3
AB - The synthesis of mitochondrial-encoded polypeptides is an essential process, primarily regulated at the posttranscriptional level. In yeast, many regulatory factors have been described as acting in association with the mitoribosome to promote efficient translation; however, the precise mechanisms by which these components function remain largely unknown. Here, we expand on findings concerning a previously studied mitoribosome interactor, Mrx9, which is found in large expressosome-like assemblies of mitoribosome clusters. Mrx9 was initially linked to mitochondrial translation and was suggested to be necessary for splicing of COX1 and COB transcripts. Previous data obtained by others in proximity labelling assays demonstrating that Mrx9 is in close proximity to both the mitoribosome exit tunnel and the prohibitin (PHB) complex. Our current experimental data show that overexpression of Mrx9 impairs the proteolytic functions of Yta10 and Yta12 within the prohibitin complex, leading to splicing defects, accumulation of aberrant polypeptides, and a noticeable impairment in the processing of the essential mitoribosomal protein bL32m. These findings support a regulatory role for Mrx9 in the PHB/m-AAA complex by modulating the activities of both Yta10 and Yta12
ER -